Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do nondiabetic patients with acute coronary syndromes and hyperglycemia benefit from insulin therapy?

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 312–313 (2008)Cite this article

boxed-textWeston C et al. for the National Audit of Myocardial Infarction Project and National Institute for Clinical Outcomes Research (2007) Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 93: 1542–1546

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Goyal A et al. (2006) Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27: 1289–1297

    Article  CAS  Google Scholar 

  2. Zarich SW and Nesto RW (2007) Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 115: e436–e439

    Article  Google Scholar 

  3. Gao F et al. (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497–1502

    Article  CAS  Google Scholar 

  4. Chaudhuri A et al. (2004) Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109: 849–854

    Article  CAS  Google Scholar 

  5. Sanofi-Aventis (online 7 November 2007) Retrospective analysis finds that initiation of insulin glargine in patients with type 2 diabetes was associated with a lower incidence rate of myocardial infarction as compared with NPH insulin [http://www.sanofi-aventis.ca/live/ca/medias/CC1E2A67-6117-4B3E-8077- 7CD98621BD50.pdf] (accessed 17 January 2008)

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. PP Singh and RM Lago are Fellows and RW Nesto is Chairman of the Department of Cardiovascular Medicine at Lahey Clinic Medical Center, Burlington, MA, USA. RW Nesto is also Associate Professor of Medicine at Harvard Medical School, Boston, MA, USA.,

    Premranjan P Singh, Rodrigo M Lago & Richard W Nesto

Authors
  1. Premranjan P Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodrigo M Lago
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard W Nesto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard W Nesto.

Ethics declarations

Competing interests

RW Nesto has received Speakers Bureau honoraria from Sanofi-Aventis. The other authors declared no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, P., Lago, R. & Nesto, R. Do nondiabetic patients with acute coronary syndromes and hyperglycemia benefit from insulin therapy?. Nat Rev Cardiol 5, 312–313 (2008). https://doi.org/10.1038/ncpcardio1156

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1156

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing